Kanakura, Yuzuru
Shirasugi, Yukari
Yamaguchi, Hiroki
Koike, Michiaki
Chou, Takaaki
Okamoto, Shinichiro
Achenbach, Heinrich
Wu, Jingyang
Nakaseko, Chiaki
Funding for this research was provided by:
Shire
Kyowa Hakko Kirin
Shionogi
Chugai Pharmaceutical
Pfizer
Eisai
Astellas
Nippon Shinyaku
Alexionpharma
Bristol-Myers Squibb
Toyama Chemical
Fujimotoseiyaku
Novartis
Celgene
Takeda
Article History
Received: 19 January 2018
Revised: 25 July 2018
Accepted: 30 July 2018
First Online: 18 August 2018
Compliance with ethical standards
:
: Yuzuru Kanakura: grants from Kyowa Hakko Kirin, Shionogi, Chugai Pharmaceutical, Pfizer, Eisai, Astellas, Nippon Shinyaku, Alexionpharma, Bristol-Myers Squibb, Toyama Chemical, and Fujimotoseiyaku. Yukari Shirasugi: honoraria from Novartis. Hiroki Yamaguchi: none. Michiaki Koike: none. Takaaki Chou: honoraria from Celgene, Novartis, Takeda, Bristol-Myers Squibb. Shinichiro Okamoto: none. Henri Achenbach: employed by Shire, stock or other interests in Shire. Jingyang Wu: employed by Shire, stock or other interests in Shire. Chiaki Nakaseko: none.